Definitive Contract 00278200212D278032001
Award Date 12/15/02
Potential Completion Date 12/31/09
Potential Value $12M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Menlo Park, CA 94025, USA
Solicitation Procedures
Not listed
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Sri International, a nonprofit research and development organization headquartered in Menlo Park, California, was awarded a definitive cost-plus-fixed-fee contract by the National Institute on Drug Abuse (NIDA) on September 30, 2004, with an ultimate completion date of June 30, 2010. The contract, valued at approximately $4.2 million, supports investigational new drug toxicology research for therapeutic candidates targeting Alzheimer's disease and other age-related conditions. The work will be...
- This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a civilian agency, to Sri International, a non-profit research and development institute. The contract, valued at $175,508.78, is for non-rodent pharmacokinetic assessment services under NIDA's Pharmacology and Toxicology for Neurotherapeutics Program (PTNP). The contract is a delivery order under the PTNP indefinite delivery vehicle (IDV) and has a cost-plus-fixed-fee pricing type. The contract does not...
- This is a Cost Plus Fixed Fee definitive contract awarded by the National Institute on Drug Abuse (NIDA), a component of the Department of Health and Human Services, to SRI International, a non-profit research institute. The $3,698,818.25 contract is for non-clinical absorption, distribution, metabolism, and excretion (ADME) studies, with a period of performance from September 19, 2016 to September 18, 2021. This award does not have a small business set-aside. SRI International, as the prime...
- This is a cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Sri International, a non-profit research and development institute. The $25,378,188.00 contract is for safety evaluations of anti-infective therapies, with a period of performance ending on July 30, 2007. Sri International, which has expertise across various scientific and engineering...
- This is a $100,322.00 cost-plus-fixed-fee definitive contract awarded by the Immediate Office of the Secretary, a civilian U.S. government agency, to Sri International, a non-profit research and development institute. The contract is for the synthesis of bulk chemicals and drugs for preclinical and clinical studies related to the treatment of neurodegenerative diseases, diabetes, congestive heart failure, oncologic and immunologic diseases. Sri International is not a small business, and the...
- This is a federal contract award by the National Institute on Drug Abuse (NIDA), a civilian agency, to SRI International, a non-profit research and development institute. The contract is for $1,907,638.77 and involves "Pharmacology and Toxicology for Neurotherapeutics Program (PTNP)" work, specifically "IND-Enabling Studies - ACT1". The award is for the purpose of de-obligating unexpended and expiring fiscal year 2020 funding. SRI International has a robust history of...
- This is a cost-plus-fixed-fee delivery order task order awarded by the Department of Health and Human Services' National Institute on Drug Abuse (NIDA) to nonprofit research institute SRI International. The contract, valued at $479,933.60, is for toxicological evaluations of potential medications over a period of performance from September 7, 2018 to September 6, 2023. SRI International has extensive experience providing research, engineering, and technical services to federal agencies such as...
- This is a federal contract award from the National Institute on Drug Abuse (NIDA), a civilian agency, to SRI International, a non-profit research and development organization. The contract is an administrative task order under the Pharmacology and Toxicology for Neurotherapeutics Program (PTNP) indefinite delivery vehicle (IDV). The total ceiling value of this award is $106,072.00, and the period of performance is from September 13, 2015 to September 12, 2016. The contract is a...
- Sri International, a non-profit research and development organization headquartered in Menlo Park, California, was awarded a parent Indefinite Delivery Indefinite Quantity (IDIQ) contract by the National Institute on Drug Abuse (NIDA) under the Pharmacology and Toxicology for Therapeutics Program (PTTP). This delivery order contract, valued at approximately $419K with a cost-plus-fixed-fee pricing structure, was awarded on September 15, 2020, with an ultimate completion date of September 17,...
- This is a $17,442,342.00 federal contract awarded to Sri International, a nonprofit research and development institute, by an unspecified U.S. government agency. The contract is a Definitive Contract using a Cost Plus Fixed Fee pricing type, with a completion date of May 31, 2007. The place of performance is California, USA. This contract does not have a set-aside designation. Sri International provides a wide range of services to the federal government through contracts and grants, including...